Blood Pressure in Middle-Aged People in Albury and Melbourne — Implications for Screening R. R. H. Lovell Session I: Prevalence and Risk Factors 01 December 2012 Pages: 2 - 5
Borderline Hypertension Discovered During Screening: Effect of Twelve Months’ Treatment M. G. McCallM. L. LambN. S. Stenhouse Session I: Prevalence and Risk Factors 01 December 2012 Pages: 6 - 11
The Prevalence of Hypertension in the United States Today D. R. Labarthe Session I: Prevalence and Risk Factors 01 December 2012 Pages: 11 - 15
Morbidity and Mortality in Hypertension A. E. Doyle Session II: Morbidity and Mortality 01 December 2012 Pages: 25 - 27
Hypertension and Strokes J. L. Corbett Session II: Morbidity and Mortality 01 December 2012 Pages: 27 - 34
Morbidity and Mortality in Untreated and Treated Hypertension: Results from the Göteborg 50- year- old Men Study K. SvärdsuddG. BerglundG. Tibblin Session II: Morbidity and Mortality 01 December 2012 Pages: 34 - 38
Mortality Patterns in Treated Hypertension: Results from Sydney Hospital G. E. Bauer Session II: Morbidity and Mortality 01 December 2012 Pages: 39 - 44
Recent Trends in Mortality at the Dunedin Hypertension Clinic F. O. Simpson Session II: Morbidity and Mortality 01 December 2012 Pages: 45 - 47
New Instruments for Measuring Blood Pressure D. R. Labarthe Session III: Measurement of Blood Pressure and Pre-Treatment Work-Up 01 December 2012 Pages: 48 - 57
Pre-Treatment Workup for Antihypertensive Treatment G. Berglund Session III: Measurement of Blood Pressure and Pre-Treatment Work-Up 01 December 2012 Pages: 60 - 65
The Kidney and Antihypertensive Therapy R. R. Bailey Session IV: Problems in the Management of Hypertension 01 December 2012 Pages: 70 - 77
The Treatment of Resistant Hypertension Priscilla S. Kincaid-Smith Session IV: Problems in the Management of Hypertension 01 December 2012 Pages: 78 - 86
The Problem of Non-Compliance in Long-Term Antihypertensive Therapy J. D. Abernethy Session IV: Problems in the Management of Hypertension 01 December 2012 Pages: 86 - 90
Adverse Drug Reactions During Treatment of Hypertension G. S. M. Kellaway Session IV: Problems in the Management of Hypertension 01 December 2012 Pages: 91 - 99
Some Aspects of the Pharmacology of β-Adrenoreceptor Blockers B. ÅbladE. CarlssonL. Ek Session V: Pharmacology of β-Adrenoreceptor Blocking Drugs 01 December 2012 Pages: 100 - 111
Clinical Pharmacokinetics ofβ-Adrenoreceptor Blockers G. JohnssonC. -G. Regårdh Session V: Pharmacology of β-Adrenoreceptor Blocking Drugs 01 December 2012 Pages: 111 - 121
Metabolic Effects ofβ-Adrenoreceptor Blockers Hendrika J. Waal-Manning Session V: Pharmacology of β-Adrenoreceptor Blocking Drugs 01 December 2012 Pages: 121 - 126
Haemodynamic Effects of β-Adrenoreceptor Blockers in Hypertension B. ÅbladB. LjungR. Sannerstedt Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 127 - 134
Effects of β-Adrenoreceptor Blocking Drugs on Adrenergic Transmission M. J. RandM. LawM. W. McCulloch Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 134 - 143
Action of Propranolol on Arterial Pressure and on Cardiovascular Reflexes P. I. KornerW. P. AndersonA. Bobik Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 143 - 150
The Role of Renin in the Antihypertensive Action of β-Adrenoreceptor Blocking Agents G. S. StokesR. M. GrahamM. A. Weber Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 150 - 156
Effects of β-Adrenoreceptor Blocking Drugs on Plasma Volume, Renin and Aldosterone as Components of Their Antihypertensive Action R. D. Gordon Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 156 - 163
Experience with β-Adrenoreceptor Blockers in Hypertension Hendrika J. Waal-Manning Session VII: Use of β-Adrenoreceptor Blocking Drugs in Hypertension 01 December 2012 Pages: 164 - 171
Use of β-Adrenoreceptor Blockers in Combination with β-Stimulators in Patients with Obstructive Lung Disease G. Johnsson Session VII: Use of β-Adrenoreceptor Blocking Drugs in Hypertension 01 December 2012 Pages: 171 - 177
Clinical and Haemodynamic Effects of Minoxidil in Refractory Hypertension R. ZacestD. B. FrewinB. Jackson Session VII: Use of β-Adrenoreceptor Blocking Drugs in Hypertension 01 December 2012 Pages: 177 - 184
Effect of β-Adrenoreceptor Blockers on Heart Rate and Blood Pressure in Dynamic and Isometric Exercise G. Nyberg Session VII: Use of β-Adrenoreceptor Blocking Drugs in Hypertension 01 December 2012 Pages: 185 - 195
Session VIII: General Discussion on the Place of β-Adrenoreceptor Blockers in Hypertension OriginalPaper 01 December 2012 Pages: 196 - 204
